Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 4.65 percent. The company reported quarterly sales of $987.00 thousand which beat the analyst consensus estimate of $711.50 thousand by 38.72 percent. This is a 135.56 percent increase over sales of $419.00 thousand the same period last year.